Universal precautions to reduce stimulant misuse in treating adult ADHD.
Where this comes from
- Record sourced from PubMed, PMID 26270429.
- Also identified by DOI 10.3949/ccjm.82a.14131.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the United States, stimulants remain the approved pharmacotherapy of choice for adults with attention-deficit/hyperactivity disorder (ADHD). Many patients respond to these drugs, but stimulants also have a significant potential for misuse. This article suggests the "universal precautions" approach to reducing these risks while promoting appropriate medication use.
Medical subject headings
- Attention Deficit Disorder with Hyperactivity
- Central Nervous System Stimulants
- Prescription Drug Misuse